# IM and IV SPL026 Drug Product in Healthy Participants

> **NCT05644093** · PHASE1 · COMPLETED · sponsor: **Small Pharma Ltd** · enrollment: 14 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** SPL026 IV
- **DRUG:** SPL026 IM

## Key facts

- **NCT ID:** NCT05644093
- **Lead sponsor:** Small Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-03
- **Primary completion:** 2023-04-05
- **Final completion:** 2023-04-05
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05644093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05644093, "IM and IV SPL026 Drug Product in Healthy Participants". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05644093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*